Company intelligence / Profile preview

The Production Board

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

TPB’s ecosystem includes both development-stage and commercial companies. Ohalo has commercial novel plant species; Triplebar and Dextera have ongoing pipeline development in synthetic biology and Synthetic D-Protein therapeutics. PinkDx and Every Company provide applications in diagnostics and nutrition

Therapeutic areas: Women's HealthRare DiseasesOther
Modalities: Small moleculeProteinBiologicSynthetic D-ProteinsPrecision gene editingGenomics
Industry: Investors

Partnerships

AlphabetAllen & Company LLCCascadeEmerson CollectiveBlackRockBaillie GiffordKoch Disruptive TechnologiesMorgan Stanley/Counterpoint GlobalFoxhaven Asset ManagementArrowmark Partners

Beyond the preview

Go deeper on The Production Board.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Production Board.

Explore the full profile